Plasma Adiponectin Levels are Associated with Insulin Sensitivity in Stroke Survivors

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 3, 2009, Pages 214-220

  Ryan, Alice S ^a   Macko, Richard F ^a   Peters, Matthew N ^a   Ivey, Frederick M ^a   Prior, Steven J ^a   Joseph, Lyndon J ^a   Hafer Macko, Charlene E ^a  

^a Division of Gerontology   (United States)

Author keywords

adiponectin; diabetes; inflammation; insulin sensitivity; Stroke

Indexed keywords

ADIPONECTIN; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; STROKE; SURVIVOR;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ANAEROBIC THRESHOLD; BLOOD GLUCOSE; BODY COMPOSITION; EXERCISE TEST; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STROKE; SURVIVORS;

EID: 65449134418     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.10.001     Document Type: Article

References (48)

1. Kernan W.N., Viscoli C.M., Inzucchi S.E., et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 165 (2005) 227-233
2. Ivey F.M., Ryan A.S., Hafer-Macko C.E., et al. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke. Cerebrovasc Dis 22 (2006) 368-371
3. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: Results from the health ABC study. Circulation 108 (2003) 2317-2322
4. Van Exel E., Gussekloo J., de Craen A.J., et al. Inflammation and stroke; the Leiden 85-plus study. Stroke 33 (2002) 1135-1138
5. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
6. Yudkin J.S., Stehouwer C.D., Emeis J.J., et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction; a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
7. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
8. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
9. Ryan A.S., Berman D.M., Nicklas B.J., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26 (2003) 2383-2388
10. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
11. Abbasi F., Chu J.W., Lamendola C., et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53 (2004) 585-590
12. Okamoto Y., Arita Y., Nishida M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 (2000) 47-50
13. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
14. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
15. Radloff L.S., and Rae D.S. Susceptibility and precipitating factors in depression: Sex differences and similarities. J Abnorm Psychol 88 (1979) 174-181
16. Ryan A.S., Muller D.C., and Elahi D. Sequential hyperglycemic-euglycemic clamp to assess beta-cell and peripheral tissue: Studies in female athletes. J Appl Physiol 91 (2001) 872-881
17. Macko R.F., DeSouza C.A., Tretter L.D., et al. Treadmill aerobic exercise training reduces the energy expenditure and cardiovascular demands of hemiparetic gait in chronic stroke patients: A preliminary report. Stroke 28 (1997) 326-330
18. Ryan A.S., Pratley R.E., Elahi D., et al. Resistive training increases fat-free mass and maintains RMR despite weight loss in postmenopausal women. J Appl Physiol 79 (1995) 818-823
19. Report of the expert committee on the diagnosis and classification of diabetes mellitus. American Diabetes Association 26 (2003) 55-200
20. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
21. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Kernan W.N., and Inzucchi S.E. Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management. Curr Treat Options Neurol 6 (2004) 443-450
23. Shinozaki K., Naritomi H., Shimizu T., et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 27 (1996) 37-43
24. Gertler M.M., Leetma H.E., Koutrouby R.J., et al. The assessment of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke 6 (1975) 77-84
25. Folsom A.R., Rasmussen M.L., Chambless L.E., et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: The atherosclerosis risk in communities (ARIC) study investigators. Diabetes Care 22 (1999) 1077-1083
26. Kernan W.N., Inzucchi S.E., Viscoli C.M., et al. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 60 (2003) 1447-1451
27. Alexander R.W. Inflammation and coronary artery disease. N Engl J Med 331 (1994) 468-469
28. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
29. Nakamura Y., Shimada K., Fukuda D., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90 (2004) 528-533
30. Shioji K., Moriwaki S., Takeuchi Y., et al. Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention. Circ J 71 (2007) 675-680
31. Lim S., Koo B.K., Cho S.W., et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS); a 42-month prospective study. Atherosclerosis 196 (2008) 398-404
32. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., et al. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36 (2005) 1915-1919
33. Chen M.P., Tsai J.C., Chung F.M., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 821-826
34. Nishimura M., Izumiya Y., Higuchi A., et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117 (2008) 216-223
35. Soderberg S., Stegmayr B., Stenlund H., et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256 (2004) 128-136
36. Koh K.K., Son J.W., Ahn J.Y., et al. Vascular effects of diet and statin in hypercholesterolemic patients. Int J Cardiol 95 (2004) 185-191
37. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
38. Isobe T., Saitoh S., Takagi S., et al. Influence of gender, age and renal function on plasma adiponectin level: The Tanno and Sobetsu study. Eur J Endocrinol 153 (2005) 91-98
39. Adamczak M., Rzepka E., Chudek J., et al. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 62 (2005) 114-118
40. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
41. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
42. Tomas E., Tsao T.S., Saha A.K., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99 (2002) 16309-16313
43. Ryan A.S., Dobrovolny C.L., Smith G.V., et al. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil 83 (2002) 1703-1707
44. Comuzzie A.G., Funahashi T., Sonnenberg G., et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86 (2001) 4321-4325
45. Gonzalez-Sanchez J.L., Zabena C.A., Martinez-Larrad M.T., et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13 (2005) 807-812
46. Jang Y., Lee J.H., Kim O.Y., et al. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin. Metabolism 55 (2006) 59-66
47. Stumvoll M., Tschritter O., Fritsche A., et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes 51 (2002) 37-41
48. Hegener H.H., Lee I.M., Cook N.R., et al. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: A nested case-control study. Clin Chem 52 (2006) 2021-2027